City Therapeutics

About:

City Therapeutics is a biopharmaceutical company focused on developing next-generation small interfering RNAs.

Website: https://www.citytx.com/

Twitter/X: CityTx_

Top Investors: AN Ventures, Fidelity, ARCH Venture Partners, Invus, Rock Springs Capital

Description:

City Therapeutics is a biopharmaceutical company focusing on engineering next-generation small-interfering RNAs (siRNAs) to enhance RNAi-based therapies. The company develops a pipeline of innovative RNAi therapeutics aimed at addressing various disease indications. City Therapeutics prioritizes improving and expanding RNAi technology to achieve better patient outcomes. The leadership team includes experienced scientists and industry professionals dedicated to advancing the field of RNA interference.

Total Funding Amount:

$135M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

Contact Email:

info(AT)citytx.com

Founders:

Ari Nowacek, John Maraganore, Robert Nelsen, Sebastian Trousil

Number of Employees:

11-50

Last Funding Date:

2024-10-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai